美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
TWYNSTA	022401	001	NDA	AMLODIPINE BESYLATE; TELMISARTAN	TABLET;ORAL	EQ 5MG BASE;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2009/10/16	2009/10/16	BOEHRINGER INGELHEIM	Discontinued
TWYNSTA	022401	002	NDA	AMLODIPINE BESYLATE; TELMISARTAN	TABLET;ORAL	EQ 10MG BASE;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2009/10/16	2009/10/16	BOEHRINGER INGELHEIM	Discontinued
TWYNSTA	022401	003	NDA	AMLODIPINE BESYLATE; TELMISARTAN	TABLET;ORAL	EQ 5MG BASE;80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2009/10/16	2009/10/16	BOEHRINGER INGELHEIM	Discontinued
TWYNSTA	022401	004	NDA	AMLODIPINE BESYLATE; TELMISARTAN	TABLET;ORAL	EQ 10MG BASE;80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2009/10/16	2009/10/16	BOEHRINGER INGELHEIM	Discontinued